Incretin-Based Therapies for the Treatment of Type 2 Diabetes: Evaluation of the Risks and Benefits-Reference-Cited by-同舟云学术

Incretin-Based Therapies for the Treatment of Type 2 Diabetes: Evaluation of the Risks and Benefits

Author:

Drucker Daniel J.¹,Sherman Steven I.²,Gorelick Fred S.³,Bergenstal Richard M.⁴,Sherwin Robert S.³,Buse John B.⁵

Affiliation:

1. Department of Medicine, Samuel Lunenfeld Research Institute, University of Toronto, Toronto, Ontario;

2. The University of Texas M.D. Anderson Cancer Center, Houston, Texas;

3. Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut;

4. International Diabetes Center, Minneapolis, Minnesota;

5. Division of Endocrinology, University of North Carolina School of Medicine, Chapel Hill, North Carolina.

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

Reference36 articles.

4. Therapeutic decision-making in type 2 diabetes: assessing the relative risks and benefits of glucose lowering medications;Bergenstal;Am J Med

Cited by 262 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献